ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1932

A2A Adenosine Receptor (A2AR) Stimulation Modulates NR4A2 Orphan Receptor Expression during Osteoclast Differentiation

Carmen Corciulo1, Tuere Wilder1 and Bruce Cronstein2, 1Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 2Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Adenosine receptors, bone biology, bone disease, osteoclasts and transcription factor

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Session Title: Biology and Pathology of Bone and Joint Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Orphan receptors comprise a large number of evolutionarily conserved molecules that have unknown ligands but may have potent biologic effects. Among these receptors are the nuclear receptors (NR) which are important regulators of gene expression; subgroup A of NR (NR4A) includes 3 members, Nurr77 (NR4A1), Nurr-1 (NR4A2) and Nor 1 (NR4A3), important regulators of many physiological and pathological conditions. NR4A2 is involved in the regulation of bone homeostasis by transactivation of the osteoprotegerin promoter in an osteoblast cell line and is also thought to reduce NFkB signaling. Because stimulation of A2AR, which markedly reduces bone resorption by osteoclasts, increases expression of NR4A2 in cells of myeloid origin (monocytes/macrophages) we determined whether NR4A2 might also play a role in regulating bone resorption as well.

Methods: Immunohistochemistry of articular bone was used to determine NR4A2 expression in bone. Osteoclast precursors were isolated from primary bone marrow cells and, along with the murine macrophage cell line RAW 264.7 cells, were induced to differentiate into osteoclasts following treatment with M-CSF and RANKL (30ng/ml). NR4A2 expression was measured in vitro by RT-PCR and Western Blot.

Results: NR4A2 is expressed in articular bone (osteoclasts, osteoblasts and osteocytes) but not articular chondrocytes. During osteoclast differentiation induced by RANKL treatment of primary osteoclast precursors there is a marked reduction of NR4A2 mRNA expression (75% of control, p<0.01). Similarly, RANKL induction of osteoclast differentiation by RAW 264.7 cells is also associated with diminished NR4A2 mRNA expression (Day 3, 99.8% reduction, p<0.01). Moreover immunofluorescence and western blotting data show cytosolic and nuclear NR4A2 negatively correlates with expression of cathepsin-K, consistent with reduced NR4A2 expression during osteoclast differentiation (nuclear NR4A2 is decreased by 27% and 49% at days 3 and 6 of osteoclast differentiation, respectively). Interestingly treatment of osteoclast precursors with CGS21680 (1 uM), a selective A2AR agonist, reverses this expression pattern, significantly increasing NR4A2 mRNA expression in both primary macrophages (2 fold increase vs control; p<0.05) and RAW 264.7 cells (51 fold increase vs control; p<0.01).

Conclusion: Reduced expression of NR4A2 is characteristic of osteoclast differentiation and stimulation of A2AR receptors on osteoclast precursors reverses both the reduction in NR4A2 expression and osteoclast differentiation.


Disclosure: C. Corciulo, None; T. Wilder, None; B. Cronstein, NIH grant, 2,Athritis foundation grant, 2,AstraZeneca, 2,Celgene, 2,Eli Lilly & Co., 5,AstraZeneca, 5,Canfite Biopharma, 1.

To cite this abstract in AMA style:

Corciulo C, Wilder T, Cronstein B. A2A Adenosine Receptor (A2AR) Stimulation Modulates NR4A2 Orphan Receptor Expression during Osteoclast Differentiation [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a2a-adenosine-receptor-a2ar-stimulation-modulates-nr4a2-orphan-receptor-expression-during-osteoclast-differentiation/. Accessed May 18, 2022.
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a2a-adenosine-receptor-a2ar-stimulation-modulates-nr4a2-orphan-receptor-expression-during-osteoclast-differentiation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.